Cargando…
The lncRNA ALMS1‐IT1 may promote malignant progression of lung adenocarcinoma via AVL9‐mediated activation of the cyclin‐dependent kinase pathway
Lung adenocarcinoma (LUAD) is the primary epithelial tumor of the lung. The lack of clinical symptoms and specific molecular diagnostic indicators during the early stages of LUAD mean that the disease may not be detected until late stages, and the 5‐year survival rate is only approximately 15%. Long...
Autores principales: | Luan, Tian, Zhang, Tian‐Ye, Lv, Zhong‐Hua, Guan, Bi‐Xi, Xu, Jian‐Yu, Li, Jian, Li, Ming‐Xu, Hu, Song‐Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091588/ https://www.ncbi.nlm.nih.gov/pubmed/33683834 http://dx.doi.org/10.1002/2211-5463.13140 |
Ejemplares similares
-
LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022) -
Hypoxia-regulated lncRNA CRPAT4 promotes cell migration via regulating AVL9 in clear cell renal cell carcinomas
por: Zhang, Wenhua, et al.
Publicado: (2018) -
LncRNA ABHD11‐AS1 promotes the development of endometrial carcinoma by targeting cyclin D1
por: Liu, Yao, et al.
Publicado: (2018) -
Novel ALMS1 mutations in Chinese patients with Alström syndrome
por: Liang, Xiaofang, et al.
Publicado: (2013) -
AVL9 is Upregulated in and Could Be a Predictive Biomarker for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)